They're apples and oranges. Cant really compare between the two....

They're apples and oranges. Cant really compare between the two. Sure it's nice to help humankind and fight diseases and all that. chances are the herpes drug is probably going to fail plus being preclinical and phase one you're easily looking at a 7-10 year timeline. The costs are astronomical, if anything I would prefer if they focused on producing what they do best such as cardiocell and collagen scaffolding. On what you're saying about market, the problem with surgeries is that you need surgeons to take up these procedures and that takes time. With APAS, you just need major corporations such as SHL to take it up and you're already ahead with a massive market share. I'm not saying that AHZ or LBT is better, they're different and unlike what you say, they both actually help humankind considerably. With time though, cardiocell and vascucell would be greatly taken up but it takes time.